Evidence map›Paper›PMID 38027417›Full record

ArticlePatient related outcome measures2023

Qualitative Exploration in Exit Interviews of Changes Observed in Clinical Trials for Individuals with Autism Spectrum Disorder Without Intellectual Disability.

Michael Chladek, Claire Burbridge, Elizabeth Gibbons, Tom Willgoss, Janice Smith, Susanne Clinch

Open access · goldAbstract read
In one paragraph

Article in Patient related outcome measures, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Michael ChladekClinical Outcome Assessments, Clinical Outcomes Solutions LLC, Chicago, IL, USA.ORCID 0000-0001-9649-4479
Claire BurbridgeClinical Outcome Assessments, Clinical Outcomes Solutions Ltd, Folkestone, Kent, UK.
Elizabeth GibbonsClinical Outcome Assessments, Clinical Outcomes Solutions Ltd, Folkestone, Kent, UK.
Tom WillgossPatient Centered Outcomes Research, Roche Products Ltd, Welwyn Garden City, Hertfordshire, UK.
Janice SmithGlobal Development, Roche Products Ltd, Welwyn Garden City, Hertfordshire, UK.
Susanne ClinchPatient Centered Outcomes Research, Roche Products Ltd, Welwyn Garden City, Hertfordshire, UK.ORCID 0000-0002-3458-0117
Roche (United Kingdom) · GBHealth Economics and Outcomes Research (United Kingdom) · GBHealth Outcomes Solutions (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To explore, from the perspective of Study Partners (SPs; eg, caregivers) of clinical trial participants with autism spectrum disorder (ASD), any changes experienced in socialization and communication over the clinical trial, how these changes manifested, and the impact these changes had on the autistic individual, the SP, and family. This helps interpret whether changes in trial outcomes were meaningful. Patients and Methods: Interviews were conducted with the SPs of individuals with ASD, without intellectual disability, from 2 clinical trials: 86 children (aged 5-12 years) or adolescents (aged 13-17 years) who took part in the aV1ation trial (83.7% male), and 41 adults (aged 18+ years) who took part in the V1aduct trial (80.5% male). The primary endpoint for both trials was change from baseline in the Vineland Results: Improvements in the Socialization domain enabled greater awareness of the feelings of others and allowed for stronger empathy and kindness. Improvements in the Communication domain allowed for the autistic individual to be better at listening and better at self-expression. Together, changes in these two domains, which were considered most important, allowed for richer, deeper relationships. Study Partners noted that improvements in these domains allowed for better integration within the family unit, decreased stress, and increased optimism about the autistic individual's future. Conclusions: The impacts of changes in either domain were synergistic, combining together to create positive experiences which in turn led to further positive impacts in other skills. These qualitative insights provide context to the changes that were observed during the clinical trial and captured using the Vineland

Indexed as

ASDAutismcommunicationinterviewmeaningful changequalitativesocializationVinelandTM-II

Identifiers

PMID38027417
PMCPMC10676099
OpenAlexW4388825689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.